|
[1]
|
Roque, W., Boni, A., Martinez-Manzano, J., et al. (2020) A Tale of Two Proteolytic Machines: Matrix Metalloprotein-ases and the Ubiquitin-Proteasome System in Pulmonary Fibrosis. International Journal of Molecular Sciences, 21, Arti-cle No. 3878. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Cabral-Pacheco, G.A., Garza-Veloz, I., Castruita-De La Rosa, C., et al. (2020) The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases. International Journal of Molecular Sciences, 21, Article No. 9739. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Pardo, A., Cabrera, S., Maldonado, M., et al. (2016) Role of Matrix Metalloproteinases in the Pathogenesis of Idiopathic Pulmonary Fibrosis. Respiratory Research, 17, 23.
|
|
[4]
|
Yadav, L., Puri, N., Rastogi, V., et al. (2014) Matrix Metalloproteinases and Cancer—Roles in Threat and Therapy. The Asian Pa-cific Journal of Cancer Prevention, 15, 1085-1091. [Google Scholar] [CrossRef]
|
|
[5]
|
Craig, V.J., Zhang, L., Hagood, J.S. and Owen, C.A. (2015) Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology, 53, 585-600.
|
|
[6]
|
Li, N., Qiu, L., Zeng, C., et al. (2021) Bioinformatic Analysis of Differentially Expressed Genes and Pathways in Idiopathic Pulmonary Fibrosis. Annals of Translational Medicine, 9, 1459. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Morais, A., Beltrão, M., Sokhatska, O., et al. (2015) Serum Metalloproteinases 1 and 7 in the Diagnosis of Idiopathic Pulmonary Fi-brosis and Other Interstitial Pneumonias. Respiratory Medicine, 109, 1063-1068. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Morishita, A., Gerber, A., Gow, C.H., et al. (2018) Cell Specific Matrix Metalloproteinase-1 Regulates Lung Metastasis Synergistically with Smoke Exposure. Journal of Cancer Re-search Forecast, 1, 1014.
|
|
[9]
|
Zhang, Q., Guo, Y., Dong, R., et al. (2015) Suppressor of Cytokine Signaling 1-Modulated Metalloproteinases and Tissue Inhibitor of Metalloproteinase in Pulmonary Fibrosis. Molecular Medicine Reports, 12, 3855-3861. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Herrera, I., Cisneros, J., Maldonado, M., et al. (2013) Matrix Metal-loproteinase (MMP)-1 Induces Lung Alveolar Epithelial Cell Migration and Proliferation, Protects from Apoptosis, and Represses Mitochondrial Oxygen Consumption. The Journal of Biological Chemistry, 288, 25964-25975. [Google Scholar] [CrossRef]
|
|
[11]
|
Gabasa, M., Arshakyan, M., Llorente, A., et al. (2020) Interleu-kin-1β Modulation of the Mechanobiology of Primary Human Pulmonary Fibroblasts: Potential Implications in Lung Repair. International Journal of Molecular Sciences, 21, Article No. 8417. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Roach, K.M., Castells, E., Dixon, K., et al. (2021) Evaluation of Pirfenidone and Nintedanib in a Human Lung Model of Fibrogenesis. Frontiers in Pharmacology, 12, Article ID: 679388. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Gabasa, M., Radisky, E.S., Ikemori, R., et al. (2021) MMP1 Drives Tumor Progression in Large Cell Carcinoma of the Lung through Fibroblast Senescence. Cancer Letters, 507, 1-12. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
García-de-Alba, C., Becerril, C., Ruiz, V., et al. (2010) Expression of Matrix Metalloproteases by Fibrocytes: Possible Role in Migration and Homing. American Journal of Respiratory and Critical Care Medicine, 182, 1144-1152. [Google Scholar] [CrossRef]
|
|
[15]
|
Xie, B., Zheng, G., Li, H., et al. (2016) Effects of the Tumor Suppressor PTEN on the Pathogenesis of Idiopathic Pulmonary Fibrosis in Chinese Patients. Molecular Medicine Re-ports, 13, 2715-2723. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Hamai, K., Iwamoto, H., Ishikawa, N., et al. (2016) Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis. Disease Markers, 2016, Article ID: 4759040. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Kristensen, J.H., Larsen, L., Dasgupta, B., et al. (2015) Levels of Cir-culating MMP-7 Degraded Elastin Are Elevated in Pulmonary Disorders. Clinical Biochemistry, 48, 1083-1088. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Mahalanobish, S., Saha, S., Dutta, S., et al. (2020) Matrix Metalloproteinase: An Upcoming Therapeutic Approach for Idiopathic Pulmonary Fibrosis. Pharmacological Research, 152, Article ID: 104591. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
White, E.S., Xia, M., Murray, S., et al. (2016) Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias. American Journal of Respiratory and Critical Care Medicine, 194, 1242-1251. [Google Scholar] [CrossRef]
|
|
[20]
|
Yue, L., Shi, Y., Su, X., et al. (2021) Matrix Metalloproteinas-es Inhibitors in Idiopathic Pulmonary Fibrosis: Medicinal Chemistry Perspectives. European Journal of Medicinal Chemistry, 224, Article ID: 113714. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Puig, M., Lugo, R., Gabasa, M., et al. (2015) Matrix Stiffening and β1 Integrin Drive Subtype-Specific Fibroblast Accumulation in Lung Cancer. Molecular Cancer Research: MCR, 13, 161-173. [Google Scholar] [CrossRef]
|
|
[22]
|
Bauer, Y., White, E.S., De Bernard, S., et al. (2017) MMP-7 Is a Predictive Biomarker of Disease Progression in Patients with Idiopathic Pulmonary Fibrosis. ERJ Open Re-search, 3, Article ID: 00074-2016. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Tzouvelekis, A., Herazo-Maya, J.D., Slade, M., et al. (2017) Validation of the Prognostic Value of MMP-7 in Idiopathic Pulmonary Fibrosis. Respirology, 22, 486-493. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Cabrera Cesar, E., Lopez-Lopez, L., Lara, E., et al. (2021) Serum Bi-omarkers in Differential Diagnosis of Idiopathic Pulmonary Fibrosis and Connective Tissue Disease-Associated Intersti-tial Lung Disease. Journal of Clinical Medicine, 10, Article No. 3167. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Wan, H., Huang, X., Cong, P., et al. (2021) Identification of Hub Genes and Pathways Associated with Idiopathic Pulmonary Fibrosis via Bioinformatics Analysis. Frontiers in Molecular Bio-sciences, 8, Article ID: 711239. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Chulia-Peris, L., Carreres-Rey, C., Gabasa, M., et al. (2022) Ma-trix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play. International Journal of Molecular Sciences, 23, Article No. 6894. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Summer, R., Krishna, R., Schriner, D., et al. (2019) Matrix Metallopro-teinase Activity in the Lung Is Increased in Hermansky-Pudlak Syndrome. Orphanet Journal of Rare Diseases, 14, Arti-cle No. 162. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Murthy, S., Ryan, A., He, C., et al. (2010) Rac1-Mediated Mito-chondrial H2O2 Generation Regulates MMP-9 Gene Expression in Macrophages via Inhibition of SP-1 and AP-1. The Journal of Biological Chemistry, 285, 25062-25073. [Google Scholar] [CrossRef]
|
|
[29]
|
Molyneaux, P.L., Willis-Owen, S.A.G., Cox, M.J., et al. (2017) Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medi-cine, 195, 1640-1650. [Google Scholar] [CrossRef]
|
|
[30]
|
Todd, J.L., Vinisko, R., Liu, Y., et al. (2020) Circulating Ma-trix Metalloproteinases and Tissue Metalloproteinase Inhibitors in Patients with Idiopathic Pulmonary Fibrosis in the Multicenter IPF-PRO Registry Cohort. BMC Pulmonary Medicine, 20, Article No. 64. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Li, G., Jin, F., Du, J., et al. (2019) Macrophage-Secreted TSLP and MMP9 Promote Bleomycin-Induced Pulmonary Fibrosis. Toxicology and Applied Pharmacology, 366, 10-16. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Dong, C., Gongora, R., Sosulski, M.L., et al. (2016) Regulation of Transforming Growth Factor-Beta1 (TGF-β1)- Induced Pro-Fibrotic Activities by Circadian Clock Gene BMAL1. Res-piratory Research, 17, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
|